← Leaderboards
Charles Patrick Lusk
Yale University
$10,893,306
Attributed
$19,136,366
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,136,366 · 11
By mechanism
R01$15,402,816 · 5
R21$1,775,997 · 4
T32$1,614,344 · 1
R56$343,209 · 1
Top collaborators
- Mustafa K Khokha9 shared
- Jeffrey D Rothstein8 shared
- Thomas James Melia6 shared
- Joerg Bewersdorf4 shared
- Martina Brueckner4 shared
- Megan C King4 shared
- Susan J Baserga3 shared
- Chenxiang Lin2 shared
Most similar at Yale University
Same institution · by research overlap
- Derek K. Toomre$7,124,112
- Chenxiang Lin$8,574,232
- David Baddeley$1,446,667
- Kristen Jennifer Brennand$23,065,666
- Yansheng Liu$3,478,782
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularProteinsPathway InteractionsNuclear Pore ComplexNuclearNuclear EnvelopeEventCell NucleusMembraneExperimental StudyCytoplasmNucleocytoplasmic TransportGenesComplexNuclear Pore Complex ProteinsCellsMediatingNeurodegenerative DisordersLinkGeneticLightInsightBaseLead
Grant awards (45)
Nuclear pore complex quality control in ALS/FTD$772,375
R01 · FY2025 · NS
The mechanism of nucleophagy in rejuvenating the nuclear envelope$656,709
R01 · FY2025 · AG · contact PI
Nuclear transport of developmental signaling effectors$630,169
R01 · FY2025 · HL
Predoctoral Program in Cellular, Molecular and Quantitative Biology (CMQBTP)$534,450
T32 · FY2025 · GM
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$352,756
R01 · FY2025 · GM · contact PI
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$47,738
R01 · FY2025 · GM · contact PI
Nuclear pore complex quality control in ALS/FTD$772,375
R01 · FY2024 · NS
Predoctoral Program in Cellular, Molecular and Quantitative Biology (CMQBTP)$549,359
T32 · FY2024 · GM
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$340,973
R01 · FY2024 · GM · contact PI
Nuclear pore complex quality control in ALS/FTD$63,650
R01 · FY2024 · NS
Nuclear pore complex quality control in ALS/FTD$772,375
R01 · FY2023 · NS
Predoctoral Program in Cellular, Molecular and Quantitative Biology (CMQBTP)$530,535
T32 · FY2023 · GM
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$340,987
R01 · FY2023 · GM · contact PI
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$211,150
R01 · FY2023 · GM · contact PI
Nuclear pore complex quality control in ALS/FTD$19,541
R01 · FY2023 · NS
Nuclear pore complex quality control in ALS/FTD$772,375
R01 · FY2022 · NS
New Mechanisms of Heterotaxy and Congenital Heart Disease: Nucleoporins at Cilia$592,085
R01 · FY2022 · HL
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$353,677
R01 · FY2022 · GM · contact PI
The mechanism of nuclear autophagy$343,209
R56 · FY2022 · AG · contact PI
Nuclear pore complex quality control in ALS/FTD$44,108
R01 · FY2022 · NS
Nuclear pore complex quality control in ALS/FTD$788,313
R01 · FY2021 · NS
New Mechanisms of Heterotaxy and Congenital Heart Disease: Nucleoporins at Cilia$592,085
R01 · FY2021 · HL
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$343,375
R01 · FY2021 · GM · contact PI
New Mechanisms of Heterotaxy and Congenital Heart Disease: Nucleoporins at Cilia$592,085
R01 · FY2020 · HL
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$343,375
R01 · FY2020 · GM · contact PI
Leveraging cancer-specific defects in nuclear integrity to inform novel synthetic lethal strategies$182,156
R21 · FY2020 · CA · contact PI
New Mechanisms of Heterotaxy and Congenital Heart Disease: Nucleoporins at Cilia$592,085
R01 · FY2019 · HL
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$343,375
R01 · FY2019 · GM · contact PI
Leveraging cancer-specific defects in nuclear integrity to inform novel synthetic lethal strategies$218,588
R21 · FY2019 · CA · contact PI
Defining the Nucleophagy Mechanism: Opening New Doors for Aging Research$209,375
R21 · FY2019 · AG
New mechanisms of heterotaxy and congenital heart disease: nucleoporins at cilia$770,028
R01 · FY2018 · HL
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier$343,375
R01 · FY2018 · GM · contact PI
Defining the Nucleophagy Mechanism: Opening New Doors for Aging Research$250,440
R21 · FY2018 · AG
New mechanisms of heterotaxy and congenital heart disease: nucleoporins at cilia$794,337
R01 · FY2017 · HL
Establishing a blueprint for nuclear pore complex assembly$315,410
R01 · FY2017 · GM · contact PI
New mechanisms of heterotaxy and congenital heart disease: nucleoporins at cilia$794,337
R01 · FY2016 · HL
Establishing a blueprint for nuclear pore complex assembly$315,471
R01 · FY2016 · GM · contact PI
New mechanisms of heterotaxy and congenital heart disease: nucleoporins at cilia$794,337
R01 · FY2015 · HL
Establishing a blueprint for nuclear pore complex assembly$315,531
R01 · FY2015 · GM · contact PI
Generating nuclear pore complex mimics with DNA origami$208,125
R21 · FY2015 · GM
Establishing a blueprint for nuclear pore complex assembly$315,592
R01 · FY2014 · GM · contact PI
Generating nuclear pore complex mimics with DNA origami$249,750
R21 · FY2014 · GM
Genomic Regulation at the Nuclear Periphery$208,125
R21 · FY2014 · HG · contact PI
Establishing a blueprint for nuclear pore complex assembly$306,662
R01 · FY2013 · GM · contact PI
Genomic Regulation at the Nuclear Periphery$249,438
R21 · FY2013 · HG · contact PI